Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Feb;7(1):155-159.
doi: 10.21037/tau.2017.12.26.

Biomarkers in active surveillance

Stacy Loeb  1   2   3 , Jeffrey J Tosoian  4
Affiliations
Review

Biomarkers in active surveillance

Stacy Loeb et al. Transl Androl Urol. 2018 Feb.

Abstract

The use of active surveillance (AS) is increasing for favorable-risk prostate cancer. However, there remain challenges in patient selection for AS, due to the limitations of current clinical staging. In addition, monitoring protocols relying on serial biopsies is invasive and presents risks such as infection. For these reasons, there is substantial interest in identifying markers that can be used to improve AS selection and monitoring. In this article, we review the evidence on serum, urine and tissue markers in AS.

Keywords: Prostate cancer; active surveillance (AS); biomarkers; markers.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: S Loeb received honoraria for lectures from Astellas, MDxHealth and Boehringer Ingelheim, reimbursed travel from Sanofi and Astellas, and consulting for GE, GenomeDx Biosciences and Lilly (unrelated to the current manuscript). JJ Tosoian has no conflicts of interest to declare.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Chen RC, Rumble RB, Loblaw DA, et al. Active Surveillance for the Management of Localized Prostate Cancer (Cancer Care Ontario Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement. J Clin Oncol 2016;34:2182-90. 10.1200/JCO.2015.65.7759 - DOI - PubMed
    1. Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Available online: http://www.auanet.org/guidelines/clinically-localized-prostate-cancer-new-(aua/astro/suo-guideline-2017)
    1. Hamdy FC, Donovan JL, Lane JA, et al. 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer. N Engl J Med 2016;375:1415-24. 10.1056/NEJMoa1606220 - DOI - PubMed
    1. Loeb S, Carter HB, Schwartz M, et al. Heterogeneity in active surveillance protocols worldwide. Rev Urol 2014;16:202-3. - PMC - PubMed
    1. Loeb S, Curnyn C, Fagerlin A, et al. A Qualitative Study on Decision-Making by Prostate Cancer Physicians during Active Surveillance. BJU Int 2017;120:32-9. 10.1111/bju.13651 - DOI - PMC - PubMed